Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in Uganda

NCT02606526 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4500

Enrollment

OTHER

Sponsor class

Conditions

Severe Illness
Septicaemia
Diarrhoea
Lower Respiratory Infection

Interventions

BIOLOGICAL: BCG at birth
BIOLOGICAL: Control arm: Delayed BCG

Sponsor

Makerere University

Collaborators

[object Object]
[object Object]